Leap therapeutics reports second quarter 2021 financial results and upcoming data presentation

Cambridge, mass., aug. 13, 2021 /prnewswire/ -- leap therapeutics, inc. (nasdaq: lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the second quarter ended june 30, 2021 and provided upcoming company milestones.

LPTX Ratings Summary

LPTX Quant Ranking